Literature DB >> 9668067

Product release is the major contributor to kcat for the hepatitis C virus helicase-catalyzed strand separation of short duplex DNA.

D J Porter1, S A Short, M H Hanlon, F Preugschat, J E Wilson, D H Willard, T G Consler.   

Abstract

Hepatitis C virus (HCV) helicase catalyzes the ATP-dependent strand separation of duplex RNA and DNA containing a 3' single-stranded tail. Equilibrium and velocity sedimentation centrifugation experiments demonstrated that the enzyme was monomeric in the presence of DNA and ATP analogues. Steady-state and pre-steady-state kinetics for helicase activity were monitored by the fluorescence changes associated with strand separation of F21:HF31 that was formed from a 5'-hexachlorofluorescein-tagged 31-mer (HF31) and a complementary 3'-fluorescein-tagged 21-mer (F21). kcat for this reaction was 0.12 s-1. The fluorescence change associated with strand separation of F21:HF31 by excess enzyme and ATP was a biphasic process. The time course of the early phase (duplex unwinding) suggested only a few base pairs ( approximately 2) were disrupted concertedly. The maximal value of the rate constant (keff) describing the late phase of the reaction (strand separation) was 0. 5 s-1, which was 4-fold greater than kcat. Release of HF31 from E. HF31 in the presence of ATP (0.21 s-1) was the major contributor to kcat. At saturating ATP and competitor DNA concentrations, the enzyme unwound 44% of F21:HF31 that was initially bound to the enzyme (low processivity). These results are consistent with a passive mechanism for strand separation of F21:HF31 by HCV helicase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9668067     DOI: 10.1074/jbc.273.30.18906

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Mutations that affect dimer formation and helicase activity of the hepatitis C virus helicase.

Authors:  Y L Khu; E Koh; S P Lim; Y H Tan; S Brenner; S G Lim; W J Hong; P Y Goh
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

2.  Uncoupling DNA translocation and helicase activity in PcrA: direct evidence for an active mechanism.

Authors:  P Soultanas; M S Dillingham; P Wiley; M R Webb; D B Wigley
Journal:  EMBO J       Date:  2000-07-17       Impact factor: 11.598

3.  Defining the roles of individual residues in the single-stranded DNA binding site of PcrA helicase.

Authors:  M S Dillingham; P Soultanas; P Wiley; M R Webb; D B Wigley
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

4.  The nonstructural protein 3 protease/helicase requires an intact protease domain to unwind duplex RNA efficiently.

Authors:  David N Frick; Ryan S Rypma; Angela M I Lam; Baohua Gu
Journal:  J Biol Chem       Date:  2003-10-29       Impact factor: 5.157

5.  Global analysis of non-specific protein-nucleic interactions by sedimentation equilibrium.

Authors:  Jason W Ucci; James L Cole
Journal:  Biophys Chem       Date:  2004-03-01       Impact factor: 2.352

Review 6.  Understanding helicases as a means of virus control.

Authors:  D N Frick; A M I Lam
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 7.  Step-by-step progress toward understanding the hepatitis C virus RNA helicase.

Authors:  David N Frick
Journal:  Hepatology       Date:  2006-06       Impact factor: 17.425

8.  Hepatitis C virus NS3 helicase forms oligomeric structures that exhibit optimal DNA unwinding activity in vitro.

Authors:  Bartek Sikora; Yingfeng Chen; Cheryl F Lichti; Melody K Harrison; Thomas A Jennings; Yong Tang; Alan J Tackett; John B Jordan; Joshua Sakon; Craig E Cameron; Kevin D Raney
Journal:  J Biol Chem       Date:  2008-02-18       Impact factor: 5.157

9.  Three conformational snapshots of the hepatitis C virus NS3 helicase reveal a ratchet translocation mechanism.

Authors:  Meigang Gu; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-31       Impact factor: 11.205

10.  Monitoring helicase activity with molecular beacons.

Authors:  Craig A Belon; David N Frick
Journal:  Biotechniques       Date:  2008-10       Impact factor: 1.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.